SNPE Sells U.S. Subsidiary; Eyes Peptides Sell Off

SNPE (Paris) says it has sold its U.S. fine chemicals subsidiary, Isochem (Lockport, NY), to private equity firm Buckingham Capital Partners (New York) for an undisclosed sum. SNPE says it decided to divest the U.S. business, which represents 10% of Isochem, to decrease group debt and enable the company to refocus on its European production sites. Separately, SNPE tells CW it “may divest” its peptides business. Further details were not disclosed. Buckingham has renamed the acquired business VanDeMark Chemical, which was its original name. VanDeMark...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers